These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 36402782

  • 1. Lassa antiviral LHF-535 protects guinea pigs from lethal challenge.
    Cashman KA, Wilkinson ER, Posakony J, Madu IG, Tarcha EJ, Lustig KH, Korth MJ, Bedard KM, Amberg SM.
    Sci Rep; 2022 Nov 19; 12(1):19911. PubMed ID: 36402782
    [Abstract] [Full Text] [Related]

  • 2. A potent Lassa virus antiviral targets an arenavirus virulence determinant.
    Madu IG, Files M, Gharaibeh DN, Moore AL, Jung KH, Gowen BB, Dai D, Jones KF, Tyavanagimatt SR, Burgeson JR, Korth MJ, Bedard KM, Iadonato SP, Amberg SM.
    PLoS Pathog; 2018 Dec 19; 14(12):e1007439. PubMed ID: 30576397
    [Abstract] [Full Text] [Related]

  • 3. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.
    Safronetz D, Rosenke K, Westover JB, Martellaro C, Okumura A, Furuta Y, Geisbert J, Saturday G, Komeno T, Geisbert TW, Feldmann H, Gowen BB.
    Sci Rep; 2015 Oct 12; 5():14775. PubMed ID: 26456301
    [Abstract] [Full Text] [Related]

  • 4. DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs.
    Cashman KA, Wilkinson ER, Wollen SE, Shamblin JD, Zelko JM, Bearss JJ, Zeng X, Broderick KE, Schmaljohn CS.
    Hum Vaccin Immunother; 2017 Dec 02; 13(12):3010-3019. PubMed ID: 29135337
    [Abstract] [Full Text] [Related]

  • 5. Lethal Infection of Lassa Virus Isolated from a Human Clinical Sample in Outbred Guinea Pigs without Adaptation.
    Maruyama J, Manning JT, Mateer EJ, Sattler R, Bukreyeva N, Huang C, Paessler S.
    mSphere; 2019 Sep 25; 4(5):. PubMed ID: 31554720
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model.
    Kainulainen MH, Spengler JR, Welch SR, Coleman-McCray JD, Harmon JR, Klena JD, Nichol ST, Albariño CG, Spiropoulou CF.
    J Infect Dis; 2018 May 25; 217(12):1957-1966. PubMed ID: 29800368
    [Abstract] [Full Text] [Related]

  • 13. Temporal Progression of Lesions in Guinea Pigs Infected With Lassa Virus.
    Bell TM, Shaia CI, Bearss JJ, Mattix ME, Koistinen KA, Honnold SP, Zeng X, Blancett CD, Donnelly GC, Shamblin JD, Wilkinson ER, Cashman KA.
    Vet Pathol; 2017 May 25; 54(3):549-562. PubMed ID: 28438110
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunogenicity of a protective intradermal DNA vaccine against lassa virus in cynomolgus macaques.
    Jiang J, Banglore P, Cashman KA, Schmaljohn CS, Schultheis K, Pugh H, Nguyen J, Humeau LM, Broderick KE, Ramos SJ.
    Hum Vaccin Immunother; 2019 May 25; 15(9):2066-2074. PubMed ID: 31071008
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.